Pulmonary Disease Chronic Obstructive
Conditions
Interventions
This is a two-arm, single-blind, randomized controlled clinical trial. Experimental group: 21 male and female patients with moderate to severe chronic obstructive pulmonary disease, patients will be e
E02.774
Sponsors
Universidade Federal de São Carlos
Universidade Federal de São Carlos
Eligibility
Age
40 Years to No maximum
Inclusion criteria
Inclusion criteria: Patients of both sexes; over forty years of age forty years or older; with a clinical diagnosis of Chronic Obstructive Pulmonary Disease - COPD; classified by Chronic Obstructive Lung Disease GOLD as moderate and severe; clinically stable; non-smokers and former smokers; without exacerbations in the last four weeks; and who have not participated in any application of whole-body light
Exclusion criteria
Exclusion criteria: Patients who present exacerbation of symptoms in the four weeks prior to the collections; those with spinal cord trauma that prevents the tests from being performed; chronic neurological disorder; progressive neuromuscular disease; recent cancer treatment; symptoms of exertion intolerance at baseline such as: respiratory rate greater than 35 breaths per minute, signs of respiratory distress, use of accessory muscles, paradoxical breathing, saturation less than 85 and heart rate greater than 120 beats per minute at rest and breathing in room air
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| It is expected to find a decrease in dyspnea and fatigue of the lower limbs in TSL5x, TSL1' and TME2' after the application of whole-body light. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcomes are not expected. | — |
Countries
Brazil
Contacts
Public ContactThais Paula Michelato
Universidade Federal de São Carlos
Outcome results
None listed